Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
05/13/2024 | UBS GROUP AG | 304,979 | $9.83 M | -0.52% | 0.27% |
05/14/2024 | ALLIANCEBERNSTEIN L.P. | 323,364 | $10.42 M | 0.97% | 0.29% |
04/04/2024 | MASS GENERAL BRIGHAM, INC | 338,191 | $10.90 M | 100.00% | 0.30% |
05/15/2024 | EVENTIDE ASSET MANAGEMENT, LLC | 361,000 | $11.64 M | 0.00% | 0.32% |
05/13/2024 | NUVEEN ASSET MANAGEMENT, LLC | 373,775 | $12.05 M | -2.83% | 0.33% |
05/15/2024 | INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 420,000 | $13.54 M | 110.00% | 0.37% |
05/15/2024 | MIC CAPITAL MANAGEMENT UK LLP | 508,569 | $16.39 M | 0.00% | 0.45% |
05/15/2024 | DAFNA CAPITAL MANAGEMENT LLC | 511,894 | $16.50 M | 0.00% | 0.45% |
04/25/2024 | BANK OF NEW YORK MELLON CORP | 529,409 | $17.06 M | -8.91% | 0.47% |
05/15/2024 | BANK OF AMERICA CORP /DE/ | 544,086 | $17.54 M | 121.17% | 0.48% |
05/06/2024 | CANDRIAM S.C.A. | 583,950 | $18.82 M | -3.79% | 0.52% |
05/15/2024 | CITADEL ADVISORS LLC | 588,088 | $18.95 M | -34.95% | 0.52% |
05/03/2024 | VICTORY CAPITAL MANAGEMENT INC | 600,581 | $19.36 M | 7.56% | 0.53% |
05/15/2024 | PERCEPTIVE ADVISORS LLC | 618,885 | $19.95 M | -24.42% | 0.55% |
05/15/2024 | AVIDITY PARTNERS MANAGEMENT LP | 635,000 | $20.47 M | 958.33% | 0.56% |
05/14/2024 | FINEPOINT CAPITAL LP | 677,100 | $21.82 M | 9.72% | 0.60% |
05/15/2024 | SOLEUS CAPITAL MANAGEMENT, L.P. | 728,700 | $23.49 M | 189.17% | 0.64% |
05/15/2024 | ROCK SPRINGS CAPITAL MANAGEMENT LP | 923,681 | $29.77 M | 27.38% | 0.82% |
05/15/2024 | MORGAN STANLEY | 927,070 | $29.88 M | -43.92% | 0.82% |
05/15/2024 | FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 997,455 | $32.15 M | 0.00% | 0.88% |
05/09/2024 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.05 M | $33.91 M | 0.89% | 0.93% |
05/15/2024 | GOLDMAN SACHS GROUP INC | 1.12 M | $36.21 M | 6.66% | 0.99% |
05/14/2024 | NORTHERN TRUST CORP | 1.21 M | $39.14 M | -4.45% | 1.07% |
05/17/2024 | ARTAL GROUP S.A. | 1.32 M | $42.50 M | -22.25% | 1.17% |
05/10/2024 | DIMENSIONAL FUND ADVISORS LP | 1.33 M | $42.91 M | -25.85% | 1.18% |
05/15/2024 | MARSHALL WACE, LLP | 1.54 M | $49.50 M | 27.05% | 1.36% |
05/13/2024 | BALYASNY ASSET MANAGEMENT L.P. | 1.65 M | $53.34 M | 191.81% | 1.46% |
05/15/2024 | AMERIPRISE FINANCIAL INC | 1.69 M | $54.61 M | 4.40% | 1.50% |
05/15/2024 | HOLOCENE ADVISORS, LP | 2.42 M | $78.07 M | -15.95% | 2.14% |
05/15/2024 | AH CAPITAL MANAGEMENT, L.L.C. | 2.75 M | $88.58 M | -51.76% | 2.43% |
05/15/2024 | PARADIGM BIOCAPITAL ADVISORS LP | 2.91 M | $93.95 M | 100.00% | 2.58% |
05/13/2024 | GEODE CAPITAL MANAGEMENT, LLC | 3.05 M | $98.40 M | 2.48% | 2.70% |
05/15/2024 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3.09 M | $99.59 M | 0.00% | 2.73% |
05/10/2024 | JPMORGAN CHASE & CO | 3.51 M | $113.10 M | -20.10% | 3.10% |
05/15/2024 | WOODLINE PARTNERS LP | 3.80 M | $122.38 M | 28.28% | 3.36% |
05/15/2024 | JANUS HENDERSON GROUP PLC | 3.91 M | $126.07 M | 77.87% | 3.46% |
05/13/2024 | FMR LLC | 4.17 M | $134.29 M | 0.06% | 3.68% |
05/15/2024 | BOXER CAPITAL, LLC | 4.28 M | $137.93 M | 0.00% | 3.78% |
05/15/2024 | PRICE T ROWE ASSOCIATES INC /MD/ | 4.81 M | $155.17 M | 3.84% | 4.25% |
05/15/2024 | BELLEVUE GROUP AG | 5.07 M | $163.52 M | -0.34% | 4.48% |
05/03/2024 | ALPHABET INC. | 5.30 M | $170.87 M | 0.00% | 4.69% |
05/15/2024 | STATE STREET CORP | 5.39 M | $173.59 M | -13.87% | 4.76% |
05/15/2024 | CASDIN CAPITAL, LLC | 5.62 M | $181.06 M | -1.70% | 4.96% |
05/15/2024 | BVF INC/IL | 5.98 M | $192.77 M | 0.00% | 5.29% |
05/15/2024 | NEXTECH INVEST LTD. | 6.30 M | $202.94 M | 0.00% | 5.57% |
05/24/2024 | FARALLON CAPITAL MANAGEMENT LLC | 7.51 M | $241.98 M | 11.44% | 6.64% |
05/15/2024 | BAKER BROS. ADVISORS LP | 7.55 M | $243.31 M | 46.63% | 6.67% |
05/10/2024 | BLACKROCK INC. | 12.31 M | $396.69 M | -4.99% | 10.88% |
05/15/2024 | WELLINGTON MANAGEMENT GROUP LLP | 14.71 M | $474.26 M | -1.12% | 13.00% |
05/10/2024 | VANGUARD GROUP INC | 14.76 M | $475.62 M | 0.84% | 13.04% |
A. During the previous two years, 258 institutional investors and hedge funds held shares of Revolution Medicines, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 14.76 M
WELLINGTON MANAGEMENT GROUP LLP: 14.71 M
BlackRock Inc.: 12.31 M
BAKER BROS. ADVISORS LP: 7.55 M
FARALLON CAPITAL MANAGEMENT LLC: 7.51 M
Nextech Invest Ltd.: 6.3 M
A. 140.36% of Revolution Medicines, Inc. stock is owned by institutional investors.
A. Institutional investors have bought a total of 214.00 M shares in the last 24 months. This purchase volume represents approximately $7.90 B in transactions.